Clinical Efficacy and Safety of Combined Mometasone Furoate and Formoterol in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease ◽

Clinical Efficacy ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Combined Mometasone Furoate and Formoterol in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Phase 3 Efficacy and Safety Study

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2011.12.605 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB75

Author(s):

D.E. Doherty ◽

E. Kerwin ◽

D.P. Tashkin ◽

C.E. Matiz-Bueno ◽

T. Shekar ◽

...

Keyword(s):

Pulmonary Disease ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Add-on therapy with EPs 7630 in patients with chronic obstructive pulmonary disease – an overview on clinical efficacy and safety

10.1055/s-0039-3400159 ◽

2019 ◽

Author(s):

H Matthys ◽

FA Malek

Keyword(s):

Pulmonary Disease ◽

Clinical Efficacy ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD)

Equine Veterinary Journal ◽

10.1111/j.2042-3306.1994.tb04396.x ◽

1994 ◽

Vol 26 (4) ◽

pp. 331-336 ◽

Cited By ~ 55

Author(s):

DEBORAH F. ERICHSEN ◽

ANITA D. AVIAD ◽

R. H. SCHULTZ ◽

T. J. KENNEDY

Keyword(s):

Pulmonary Disease ◽

Clinical Efficacy ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Efficacy and Safety of Mometasone Furoate/Formoterol in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease: Results From Two Phase Three 26-Week Trials

CHEST Journal ◽

10.1378/chest.1118460 ◽

2011 ◽

Vol 140 (4) ◽

pp. 535A ◽

Cited By ~ 2

Author(s):

Dennis Doherty ◽

Donald Tashkin ◽

Edward Kerwin ◽

Carlos Eduardo Matiz-Bueno ◽

Tulin Shekar ◽

...

Keyword(s):

Pulmonary Disease ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Two Phase ◽

Clinical efficacy ofKuanxionglifeiDecoction combined withSanziyangqinDecoction in treatment of acute exacerbation of chronic obstructive pulmonary disease

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2015.01374 ◽

2015 ◽

Vol 36 (12) ◽

pp. 1374

Author(s):

Xue-yuan HUANG ◽

Rui ZHANG ◽

Jia-ying ZHAO ◽

Ting CHEN ◽

Sha-luo LI ◽

...

Keyword(s):

Pulmonary Disease ◽

Acute Exacerbation ◽

Clinical Efficacy ◽

Chronic Obstructive ◽

Supervised physical exercise training for chronic obstructive pulmonary disease: long-term efficacy and safety

10.1002/14651858.cd006906 ◽

2008 ◽

Author(s):

Rachel Garrod ◽

Dina Brooks ◽

Toby J Lasserson ◽

E. Haydn Walters ◽

Amanda Thomson

Keyword(s):

Exercise Training ◽

Physical Exercise ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Obstructive Pulmonary Disease ◽

Term Efficacy ◽

Physical Exercise Training

Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2015.09.1383 ◽

2015 ◽

Vol 18 (7) ◽

pp. A495

Author(s):

V Taieb ◽

D Belhadi ◽

AT Nielsen ◽

M Hemels ◽

J Van Laer

Keyword(s):

Bayesian Network ◽

Pulmonary Disease ◽

Meta Analysis ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Rational Pharmacotherapy in Cardiology ◽

10.20996/1819-6446-2010-6-4-497-501 ◽

2010 ◽

Vol 6 (4) ◽

pp. 497-501

Author(s):

N. Yu. Grigorieva ◽

E. G. Sharabrin ◽

A. N. Kuznetsov

Keyword(s):

Pulmonary Disease ◽

Clinical Efficacy ◽

Generic Drug ◽

Stable Angina ◽

Chronic Obstructive ◽

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Cited By ~ 51

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Mapk Inhibitor

A Comparison of Tiotropium 18µg, Once Daily and Ipratropium 40µg, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.5.498 ◽

2005 ◽

Vol 58 (5) ◽

pp. 498 ◽

Cited By ~ 4

Author(s):

Seung Joon Kim ◽

Myung Sook Kim ◽

Sang Haak Lee ◽

Young Kyoon Kim ◽

Hwa Sik Moon ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Once Daily